That's great news, just wish "childern Autisum" was a medical condition. Maybe your post should have read "JNJ is growing, I LOVE my cannabis."
I've been looking for a way to generate short term capital losses, and this market performance makes it really simple. Just buy high in the morning and sell low in the afternoon. Pretty simple when you know what you're doing.
Perhaps, as I did, beerbaba bought PFE sometime in late 2008, and over the last 7 years has seen a nice gain and collected a substantial dividend. I understand your perspective regarding share price performance, if you've held PFE for 15 or 20 years, but you did have opportunities along the way to get out at a small loss or small gain. I too consider PFE a safe stock in an income portfolio. And from my perspective, PFE has gone nowhere but up. So, go ahead, take your best shot. Lots of hilarious things you can do with "chickenguy."
shaggy and fsbsgillie, let's remember there are many ways to make money in the market, and short term trading is one of them. And just because chicagocoin only tells us about his deals after the fact, never announcing a purchase when he makes it, and apparently NEVER taking a loss, that doesn't necessarily make him less than totally truthful. After all, he does have an algorithm, which apparently guarantees that he will, as he recommends, always buy low and sell high. So, let's just celebrate his amazing success and move on with our more mundane lives.
Yes, sorry for the typo, should have been lots of 100,000. Glad I can count on sharp-eyed posters to keep the board accurate. Other than that, it's all totally accurate. You can trust me, because I have an algorithm.
Oh, yeah, and I forgot to mention that I retired when I was 17, and I only date supermodels and Russian tennis players. The girls really go for rich old dudes.
Can't believe how easy it is to make a killing in this market. Here's what I've done for the past five days, trading always in lots of 10,000 shares. Less than that is just for sissies. On Monday, bought at the open at $9.93, sold at $10.28, profit $35K. Tuesday, in at $9.99, out at close at $10.26, profit $27K. Tuesday, looked like a downer, so shorted at $9.92, out at $9.61, profit $31K. Wednesday really fun, began with short at $9.64, closed that at $9.35, profit of $30K, not satisfied so went long at $9.35 and sold at $9.46 for another 10K profit. Today, in at $9.42, out at $9.69, profit of $27K, quit early to go play golf. I usually shoot in the high 60s. Total five-day profit of $160,000. That's a little bit on the low side of my average, so I'm going to tune up my algorithm. GLTA.
I know that possibility was floated some time ago, but none of the recent articles that I've read suggest that it will go that way. Every article states that AGN shareholders are to receive a premium, while PFE shareholders will not. AGN will split 11.3-to-1 just prior to the closure, and will thus receive 11.3 shares of PFE plc for each share currently held. PFE shareholders will receive 1 share of PGE plc for each share currently held. And every article states some version of: "Pfizer’s US stockholders will recognize a taxable gain, but not a loss, for US federal income tax purposes. The transaction is expected to be tax-free for US federal income tax purposes to Allergan shareholders."
Same thing as far as the capital gains tax being discussed. A Roth IRA is an IRA where you pay taxes on money going into your account and then all future withdrawals are tax fee. If you have either a traditional IRA or a Roth IRA, and you don't fully understand how they work relative to taxes, you should get professional advice and not rely on a message board.
Yes, unless held in a tax-deferred account such as an IRA, PFE shareholders will pay capital gains taxes. Whether it's a big bill or not depends on individual cost basis. The IRS sees the transaction as PFE share-holders selling their PFE shares and being paid with PFE llc shares. The capital gain will be the difference in PFE share price on the day of conversion versus cost basis.
"Illogical that stock holders will owe a big tax bill." Sorry, but logic has nothing to do with the taxes owed after this type of merger. Unless your PFE stock is in a tax-deferred account such as an IRA, you will owe capital gains tax based on your PFE cost basis and the value of your PFE stock on the day the company converts from PFE to PFE llc.
I've never been able to get directly into the ABBV message board, but I can get there from the ABT board. Just put ABBV into the "Get Message Board for" box at the top of this page. Not really worth the trouble, but if you want to go there, that will work.
I guess we'll just have to agree to disagree on this point. But I certainly appreciate your in-depth analysis. So many posts are lacking in thoughtful, data-based analysis.
"Albeit" is a seldom used word, nice to see a post that is both accurate from an investment standpoint and well written. And, I agree with your assessment.
Sorry, but my vote will be YES. Given the tax law situation, PFE management would be acting in bad faith and irresponsibly if it did not take full advantage of the benefits of inversion. Would I prefer to see the laws changed so that inversion isn't beneficial? Of course, and perhaps the loss of PFE will cause congress to make the needed changes. But the current situation is what it is, and this merger, and the accompanying inversion, will bring both long and short term strategic benefits. I vote YES.
Your "If . . . .then . . . ." statement makes no sense. It's similar to saying "If pigs want to fly, then the USDA should be allowed to negotiate the minimum wage." There's just no relation of the "If" part to the "then" part. And the conclusion is just silly. You're saying that if Medicare could negotiate drug costs, PFE would want to remain a US-based company? The driver for inversion is taxes, not drug costs.
Splits like that are usually done to "unlock shareholder value," with the assumption that the components can do better as freestanding companies. Given JNJ's long record of success at giving its components lots of autonomy and allowing them to be largely self-directing, I don't think that assumption is valid in this case. I hope JNJ never splits off components. As currently constructed, owning JNJ is like owning a very focused and successful health-related mutual fund. I'll be very happy to pass it along to my heirs, just as it is.